Trials / Unknown
UnknownNCT04891055
Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Prospective translational study investigating predictors of outcome in metastatic renal cell carcinoma patients treated with Nivolumab (I-Rene trial)
Detailed description
Prospective translational study investigating predictors of outcome in metastatic renal cell carcinoma patients treated with Nivolumab (I-Rene trial)
Conditions
Timeline
- Start date
- 2018-11-29
- Primary completion
- 2021-11-29
- Completion
- 2021-11-29
- First posted
- 2021-05-18
- Last updated
- 2021-05-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04891055. Inclusion in this directory is not an endorsement.